Identification of coenzyme A-related tolmetin metabolites in rats: relationship with reactive drug metabolites

References

• BAILEY, M. J. and DICKINSON, R. G., 1996, Chemical and immunochemical comparison of protein adduct formation of four carboxylate drugs in rat liver and plasma. Chemical Research in Toxicology, 9, 659–666.
   PubMed Web of Science ®Google Scholar
• BENET, L. Z., SPAHN-LANGGUTH, H., IWAKAWA, S., VOLLAND, C., MIZUMA, T., MAYER, S., MUTSCHLER, E. and LIN, E. T., 1993, Predictability of the covalent binding of acidic drugs in man. Life Sciences, 53, PL141–146.
   Google Scholar
• BRUGGER, R., REICHEL, C., ALIA, B. G., BRUNE, K., YAMAMOTO, T., TEGEDER, I. and GEISSLINGER, G., 2001, Expression of rat liver long-chain acyl-CoA synthetase and characterization of its role in the metabolism of R-ibuprofen and other fatty acid-like xenobiotics. Biochemical Pharmacology, 61, 651–656.
   PubMed Web of Science ®Google Scholar
• GREGUS, Z., FEKETE, T., HALASZI, E., GYURASICS, A. and KLAASSEN, C. D., 1998, Effects of fibrates 011 the glycine conjugation of benzoic acid in rats. Drug Metabolism and Disposition, 26, 1082–1088.
   PubMed Web of Science ®Google Scholar
• GRILLO, M. P. and BENET, L. Z., 2002, Studies on the reactivity of clofibryl-S-acyl-CoA thioester with glutathione in vitro. Drug Metabolism and Disposition, 30, 55–62.
   PubMed Web of Science ®Google Scholar
• GRINDEL, J. M., 1981, The pharmacokinetic and metabolic profile of the antiinflammatory agent tolmetin in laboratory animals and man. Drug Metabolism Reviews, 12, 363–377.
   PubMed Web of Science ®Google Scholar
• HASHIMOTO, M., MIYAZAKI, H., NAMBU, K., FUJII, 0., ARAKAWA, S., YOSHIDA, K. and UTSUI, Y., 1979, Studies on disposition and metabolism of tolmetin, a new anti-inflammatory agent, in rats and mice. Drug Metabolism and Disposition, 7, 20–23.
   Google Scholar
• HUTT, A. J. and CALDWELL, J., 1990, Amino acid conjugation. In G. J. Mulder (ed.), Conjugation Reactions in Drug Metabolism (London: Taylor & Francis), pp. 273–304.
   Google Scholar
• HYNECK, M. L., SMITH, P. C., MUNAFO, A., MCDONAGH, A. F. and BENET, L. Z., 1988, Disposition and irreversible plasma protein binding of tolmetin in humans. Clinical Pharmacology and Therapeutics, 44, 107–114.
   PubMed Web of Science ®Google Scholar
• HYNECK, M. L., SMITH, P. C., UNSELD, E. and BENET, L. Z., 1987, HPLC determinations of tolmetin, tolmetin glucuronide and its isomeric conjugates in plasma and urine. Journal of Chromatography, 420, 349–356.
   PubMed Web of Science ®Google Scholar
• IwAKI, M., OGISO, T., INAGAWA, S. and KAKEHI, K., 1999, In vitro regioselective stability of 0-1-0- and 2-0-acyl glucuronides of naproxen and their covalent binding to human serum albumin. Journal of Pharmaceutical Sciences, 88, 52–57.
   PubMed Web of Science ®Google Scholar
• KAWAGUCHI, A., YOSHIMURA, T. and OKUDA, S., 1981, A new method for the preparation of acyl-CoA thioesters. Journal of Biochemistry, 89, 337–339.
   PubMed Web of Science ®Google Scholar
• KING, A. R. and DICKINSON, R. G., 1996, The utility of the bile-exteriorized rat as a source of reactive acyl glucuronide: studies with zomepirac. Journal of Pharmacological and Toxicological Methods, 36, 131–136.
   PubMed Web of Science ®Google Scholar
• KNIGHTS, K. M, 1998, Role of hepatic fatty acid:coenzyme A ligases in the metabolism of xenobiotic carboxylic acids. Clinical and Experimental Pharmacology and Physiology, 25, 776–782.
   PubMed Web of Science ®Google Scholar
• MATHEWS, C. K. and VAN HOLDE, K. E., 1990, Biochemistry (Redwood City: Benjamin Cummings). MELEGH, B., KERNER, J., JAszAi, V. and BIEBER, L. L., 1990, Differential excretion of xenobiotic acyl- esters of carnitine due to administration of pivampicillin and valproate. Biochemical Medicine and Metabolic Biology, 43, 30–38.
   PubMedGoogle Scholar
• OLSEN, J., BJØRNSDOTTIR, I., TJORNELUND, J. and HANSEN, S. H., 2002, Chemical reactivity of the naproxen acyl glucuronide and the naproxen coenzyme A thioester towards bionucleophiles. Journal of Pharmaceutical and Biomedical Analysis, 29, 7–15.
   PubMed Web of Science ®Google Scholar
• Qiu, Y., BENET, L. Z. and BURLINGAME, A. L., 1998, Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry. Journal of Biological Chemistry, 273, 17940–17953.
   PubMed Web of Science ®Google Scholar
• Qiu, Y., BENET, L. Z. and BURLINGAME, A. L., 2001, Identification of hepatic protein targets of the reactive metabolites of the non-hepatotoxic regioisomer of acetaminophen, 3I-hydroxyacetanilide, in the mouse in vivo using two-dimensional gel electrophoresis and mass spectrometry. Advances in Experimental Medicine and Biology, 500, 663–673.
   PubMed Web of Science ®Google Scholar
• SALLUSTIO, B. C., NUNTHASOMBOON, S., DROGEMULLER, C. J. and KNIGHTS, K. M., 2000, In vitro covalent binding of nafenopin-CoA to human liver proteins. Toxicology and Applied Pharmacology, 163, 176–182.
   PubMed Web of Science ®Google Scholar
• SHORE, L. J., FENSELAU, C., KING, A. R. and DICKINSON, R. G., 1995, Characterization and formation of the glutathione conjugate of clofibric acid. Drug Metabolism and Disposition, 23, 119–123.
   PubMed Web of Science ®Google Scholar
• SMITH, P. C., MCDONAGH, A. F. and BENET, L. Z., 1986, Irreversible binding of zomiperac to plasma protein in vitro and in vivo. Journal of Clinical Investigations, 77, 934–939.
   PubMed Web of Science ®Google Scholar
• TRACY, T. S. and HALL, S. D., 1991, Determination of the epimeric composition of ibuprofenyl-CoA. Analytical Biochemistry, 195, 24–29.
   PubMed Web of Science ®Google Scholar
• WANG, M. and DICKINSON, R. G., 2000, Bile duct ligation promotes covalent drug—protein adduct formation in plasma but not in liver of rats given zomepirac. Life Sciences, 68, 525–537.
   PubMed Web of Science ®Google Scholar
• ZIA-AMIRHOSSEINI, P., HARRIS, R. Z., BRODSKY, F. M. and BENET, L. Z., 1995, Hypersensitivity to nonsteroidal anti-inflammatory drugs. Nature Medicine, 1, 2–4.
   Google Scholar
• ZIA-AMIRHOSSEINI, P., OJINGWA, J. C., SPAHN-LANGGUTH, H., MCDONAGH, A. F. and BENET, L. Z., 1994, Enhanced covalent binding of tolmetin to proteins in humans after multiple dosing. Clinical Pharmacology and Therapeutics, 55, 21–27.
   Google Scholar
• ZIMMERMAN, H. J., 1994, Hepatic injury associated with nonsteroidal anti-inflammatory drugs. In A. J. Lewis and D. E. Furst (eds), Non-Steroidal Anti-Inflammatory Drugs: Mechanisms and Clinical Uses (New York: Marcel Dekker), pp. 171–194.
   Google Scholar